chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: This spontaneous case reported by a healthcare professional, describes the occurrence of administered expired product (dose left out at 2:36 pm administered at 9:00 am the next day) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch#  unknown) for COVID-19 immunization. No medical history reported. On May 14, 2021, patient received second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19  vaccine), unknown route; 1 dosage form. On May 14, 2021, patient administered expired product (dose left out at 2:36 pm administered at 9:00 am the next day). At the time of the report, administered expired product (dose left out at 2:36 pm administered at 9:00 am the next day) outcome: unknown. Concomitant product use not reported. No treatment details added.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Administration site movement impairment, Body temperature, Vaccination site pain
Clinical narrative: Vaccination site pain; Administration site movement impairment; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Vaccination site pain) and ADMINISTRATION SITE MOVEMENT IMPAIRMENT (Administration site movement impairment) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022C21A and 039B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-May-2021, the patient experienced VACCINATION SITE PAIN (Vaccination site pain). 13-May-2021, the patient experienced ADMINISTRATION SITE MOVEMENT IMPAIRMENT (Administration site movement impairment). On 14-May-2021, ADMINISTRATION SITE MOVEMENT IMPAIRMENT (Administration site movement impairment) had resolved. At the time of the report, VACCINATION SITE PAIN (Vaccination site pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-May-2021, Body temperature: 100.3 Farad (High) 100.3.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medication were provided . No concomitant medication were provided.   This case was linked to MOD-2021-132221 (Patient Link).
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Bone pain, Chills, Dyspnoea, Impaired work ability
Clinical narrative: Call off work; Chills; Fever; Joint hurts; Shortness of breath; Bone hurts; Sore throat; Body aches; Accumulation of secretion; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), BONE PAIN (Bone hurts), OROPHARYNGEAL PAIN (Sore throat), PAIN (Body aches) and SECRETION DISCHARGE (Accumulation of secretion) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced DYSPNOEA (Shortness of breath), BONE PAIN (Bone hurts), OROPHARYNGEAL PAIN (Sore throat), PAIN (Body aches), SECRETION DISCHARGE (Accumulation of secretion), CHILLS (Chills), PYREXIA (Fever) and ARTHRALGIA (Joint hurts). On an unknown date, the patient experienced IMPAIRED WORK ABILITY (Call off work). At the time of the report, DYSPNOEA (Shortness of breath), BONE PAIN (Bone hurts), OROPHARYNGEAL PAIN (Sore throat), PAIN (Body aches), SECRETION DISCHARGE (Accumulation of secretion), IMPAIRED WORK ABILITY (Call off work), CHILLS (Chills), PYREXIA (Fever) and ARTHRALGIA (Joint hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medication was not reported treatment information was not reported
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain, Pyrexia, Secretion discharge
Clinical narrative: Call off work; Chills; Fever; Joint hurts; Shortness of breath; Bone hurts; Sore throat; Body aches; Accumulation of secretion; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), BONE PAIN (Bone hurts), OROPHARYNGEAL PAIN (Sore throat), PAIN (Body aches) and SECRETION DISCHARGE (Accumulation of secretion) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced DYSPNOEA (Shortness of breath), BONE PAIN (Bone hurts), OROPHARYNGEAL PAIN (Sore throat), PAIN (Body aches), SECRETION DISCHARGE (Accumulation of secretion), CHILLS (Chills), PYREXIA (Fever) and ARTHRALGIA (Joint hurts). On an unknown date, the patient experienced IMPAIRED WORK ABILITY (Call off work). At the time of the report, DYSPNOEA (Shortness of breath), BONE PAIN (Bone hurts), OROPHARYNGEAL PAIN (Sore throat), PAIN (Body aches), SECRETION DISCHARGE (Accumulation of secretion), IMPAIRED WORK ABILITY (Call off work), CHILLS (Chills), PYREXIA (Fever) and ARTHRALGIA (Joint hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medication was not reported treatment information was not reported
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Bedridden, Malaise
Clinical narrative: Feeling Sick; Cannot get out of bed; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MALAISE (Feeling Sick) and BEDRIDDEN (Cannot get out of bed) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid cancer. Concomitant products included CLOPIDOGREL BISULFATE (PLAVIX) for Anticoagulant therapy, METOPROLOL for Heart disease, unspecified, LEVOTHYROXINE for Thyroid cancer.   On 12-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-May-2021, the patient experienced MALAISE (Feeling Sick) and BEDRIDDEN (Cannot get out of bed). At the time of the report, MALAISE (Feeling Sick) and BEDRIDDEN (Cannot get out of bed) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant treatment medication information provided.
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Decreased appetite, Feeling cold, Inappropriate schedule of product administration, Myalgia
Clinical narrative: haven't got her second shot; elevated blood pressure; body has been cold ever since she took vaccine; loss of appetite; slept all week; sore arm; Nausea; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (haven't got her second shot), BLOOD PRESSURE INCREASED (elevated blood pressure), FEELING COLD (body has been cold ever since she took vaccine), DECREASED APPETITE (loss of appetite) and SOMNOLENCE (slept all week) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 18-Mar-2021, the patient experienced BLOOD PRESSURE INCREASED (elevated blood pressure), FEELING COLD (body has been cold ever since she took vaccine), DECREASED APPETITE (loss of appetite), SOMNOLENCE (slept all week), MYALGIA (sore arm), NAUSEA (Nausea) and VOMITING (vomiting). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (haven't got her second shot). On 25-Mar-2021, SOMNOLENCE (slept all week) outcome was unknown. At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (haven't got her second shot), BLOOD PRESSURE INCREASED (elevated blood pressure), FEELING COLD (body has been cold ever since she took vaccine), DECREASED APPETITE (loss of appetite), MYALGIA (sore arm), NAUSEA (Nausea) and VOMITING (vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient has not got second shot. Soon after the first shot had Nausea, loss of appetite, vomiting, slept all week, body had been cold ever since took vaccine, sore arm, and elevated blood pressure. Concomitant medication and treatment medications details were not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-138802 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-138802:
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Somnolence, Vomiting
Clinical narrative: haven't got her second shot; elevated blood pressure; body has been cold ever since she took vaccine; loss of appetite; slept all week; sore arm; Nausea; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (haven't got her second shot), BLOOD PRESSURE INCREASED (elevated blood pressure), FEELING COLD (body has been cold ever since she took vaccine), DECREASED APPETITE (loss of appetite) and SOMNOLENCE (slept all week) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 18-Mar-2021, the patient experienced BLOOD PRESSURE INCREASED (elevated blood pressure), FEELING COLD (body has been cold ever since she took vaccine), DECREASED APPETITE (loss of appetite), SOMNOLENCE (slept all week), MYALGIA (sore arm), NAUSEA (Nausea) and VOMITING (vomiting). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (haven't got her second shot). On 25-Mar-2021, SOMNOLENCE (slept all week) outcome was unknown. At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (haven't got her second shot), BLOOD PRESSURE INCREASED (elevated blood pressure), FEELING COLD (body has been cold ever since she took vaccine), DECREASED APPETITE (loss of appetite), MYALGIA (sore arm), NAUSEA (Nausea) and VOMITING (vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient has not got second shot. Soon after the first shot had Nausea, loss of appetite, vomiting, slept all week, body had been cold ever since took vaccine, sore arm, and elevated blood pressure. Concomitant medication and treatment medications details were not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-138802 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-138802:
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Dehydration, Diarrhoea, Headache, Nausea, Vaccination complication
Clinical narrative: really hit me bad, really feel sick; dehydrated; diarrhea for 2 days; Headache for 3 days; Nausea for 2 days; puking my guts out\could not keep anything down; Nausea; Headache for 3 days; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (really hit me bad, really feel sick), DEHYDRATION (dehydrated), DIARRHOEA (diarrhea for 2 days), the first episode of HEADACHE (Headache for 3 days) and NAUSEA (Nausea for 2 days) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048821A and 037821A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  The patient's past medical history included Breast cancer and Surgery (surgery on left side due to beast cancer 4 yrs ago.).   On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (really hit me bad, really feel sick), DEHYDRATION (dehydrated), DIARRHOEA (diarrhea for 2 days), the first episode of HEADACHE (Headache for 3 days), NAUSEA (Nausea for 2 days), VOMITING (puking my guts out\could not keep anything down), NAUSEA (Nausea) and the second episode of HEADACHE (Headache for 3 days). At the time of the report, VACCINATION COMPLICATION (really hit me bad, really feel sick), DEHYDRATION (dehydrated), DIARRHOEA (diarrhea for 2 days), NAUSEA (Nausea for 2 days), VOMITING (puking my guts out\could not keep anything down), NAUSEA (Nausea) and the last episode of HEADACHE (Headache for 3 days) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant drugs used were Oral medication for breast cancer. No treatment drugs were used.   This case was linked to MOD-2021-138850 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 17-Jun-2021: TCR : AE outcome.event outcomes were updated.dose information was updated
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: really hit me bad, really feel sick; dehydrated; diarrhea for 2 days; Headache for 3 days; Nausea for 2 days; puking my guts out\could not keep anything down; Nausea; Headache for 3 days; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (really hit me bad, really feel sick), DEHYDRATION (dehydrated), DIARRHOEA (diarrhea for 2 days), the first episode of HEADACHE (Headache for 3 days) and NAUSEA (Nausea for 2 days) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048821A and 037821A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  The patient's past medical history included Breast cancer and Surgery (surgery on left side due to beast cancer 4 yrs ago.).   On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (really hit me bad, really feel sick), DEHYDRATION (dehydrated), DIARRHOEA (diarrhea for 2 days), the first episode of HEADACHE (Headache for 3 days), NAUSEA (Nausea for 2 days), VOMITING (puking my guts out\could not keep anything down), NAUSEA (Nausea) and the second episode of HEADACHE (Headache for 3 days). At the time of the report, VACCINATION COMPLICATION (really hit me bad, really feel sick), DEHYDRATION (dehydrated), DIARRHOEA (diarrhea for 2 days), NAUSEA (Nausea for 2 days), VOMITING (puking my guts out\could not keep anything down), NAUSEA (Nausea) and the last episode of HEADACHE (Headache for 3 days) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant drugs used were Oral medication for breast cancer. No treatment drugs were used.   This case was linked to MOD-2021-138850 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 17-Jun-2021: TCR : AE outcome.event outcomes were updated.dose information was updated
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: Patient is pregnant and received both doses.; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Patient is pregnant and received both doses.) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039B21A and 021C21A) for COVID-19 vaccination.     Concomitant products included BUPROPION HYDROCHLORIDE (WELLBUTRIN), LAMOTRIGINE (LAMICTAL) and LORAZEPAM for an unknown indication.   On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on 15-Aug-2020 and the estimated date of delivery was 18-Jun-2021. On 13-Apr-2021, the patient experienced EXPOSURE DURING PREGNANCY (Patient is pregnant and received both doses.). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-fourth week of the pregnancy.  On 13-Apr-2021, EXPOSURE DURING PREGNANCY (Patient is pregnant and received both doses.) had resolved.
Sex: F
Vaccine: COVID19
Symptoms: Alopecia areata, Inappropriate schedule of product administration, Rash
Clinical narrative: Second dose given less than 25 days from first dose; Alopecia Areata, hair shredding; Skin patches; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA AREATA (Alopecia Areata, hair shredding), RASH (Skin patches) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose given less than 25 days from first dose) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     There was a no medical history provided by the consumer.  Concomitant products included Multivitamins B12 and B6 for Product used for unknown indication, BIOTIN for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced ALOPECIA AREATA (Alopecia Areata, hair shredding) and RASH (Skin patches). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose given less than 25 days from first dose).        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Skin swelling, Vaccination site swelling
Clinical narrative: bumps all over her arms and shoulders, primarily on right arm and back of right shoulder and 4 bumps on left arm; noticed first bump on injection site; This spontaneous case was reported by a consumer and describes the occurrence of SKIN SWELLING (bumps all over her arms and shoulders, primarily on right arm and back of right shoulder and 4 bumps on left arm) and VACCINATION SITE SWELLING (noticed first bump on injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced SKIN SWELLING (bumps all over her arms and shoulders, primarily on right arm and back of right shoulder and 4 bumps on left arm) and VACCINATION SITE SWELLING (noticed first bump on injection site). At the time of the report, SKIN SWELLING (bumps all over her arms and shoulders, primarily on right arm and back of right shoulder and 4 bumps on left arm) outcome was unknown.            Reporter did not allow further contact
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache
Clinical narrative: Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and HEADACHE (Headache) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008C21A and 041821A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included PARACETAMOL (TYLENOL) from 18-May-2021 to an unknown date for Body temperature, PREDNISONE for an unknown indication.   On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-May-2021, the patient experienced CHILLS (Chills) and HEADACHE (Headache). At the time of the report, CHILLS (Chills) and HEADACHE (Headache) outcome was unknown.            Concomitant products include patient used medicine for liver problems. Patient took Tylenol but the temperature came back. Action taken in response to mRNA-1273 was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Agitation, Asthenia, Back pain, Chest discomfort, Dizziness
Clinical narrative: cannot move; cannot open eyes; dizzy; really tired; weak; pain in upper back; sticking out tongue to get a deep enough breath; tingling in feet and hands; itching in feet and hands; swelling in feet and hands; pressure on chest; shallow breathing; wheezing; throat closed up; whole body swelled up; ears ringing; easily agitated; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling in feet and hands), PRURITUS (itching in feet and hands), PERIPHERAL SWELLING (swelling in feet and hands), CHEST DISCOMFORT (pressure on chest) and HYPOPNOEA (shallow breathing) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No Adverse Events. Concomitant products included ZOLPIDEM TARTRATE (AMBIEN) for Product used for unknown indication, ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.    On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, the patient experienced PARAESTHESIA (tingling in feet and hands), PRURITUS (itching in feet and hands), PERIPHERAL SWELLING (swelling in feet and hands), CHEST DISCOMFORT (pressure on chest), HYPOPNOEA (shallow breathing), WHEEZING (wheezing), OROPHARYNGEAL DISCOMFORT (throat closed up), SWELLING (whole body swelled up), TINNITUS (ears ringing) and AGITATION (easily agitated). On 02-Jun-2021, the patient experienced HYPOKINESIA (cannot move), OCULAR DISCOMFORT (cannot open eyes), DIZZINESS (dizzy), FATIGUE (really tired), ASTHENIA (weak), BACK PAIN (pain in upper back) and DYSPNOEA (sticking out tongue to get a deep enough breath). On 20-May-2021, CHEST DISCOMFORT (pressure on chest), HYPOPNOEA (shallow breathing), WHEEZING (wheezing), OROPHARYNGEAL DISCOMFORT (throat closed up), SWELLING (whole body swelled up), TINNITUS (ears ringing) and AGITATION (easily agitated) outcome was unknown. At the time of the report, PARAESTHESIA (tingling in feet and hands), PRURITUS (itching in feet and hands), PERIPHERAL SWELLING (swelling in feet and hands), HYPOKINESIA (cannot move), OCULAR DISCOMFORT (cannot open eyes), FATIGUE (really tired), ASTHENIA (weak), BACK PAIN (pain in upper back) and DYSPNOEA (sticking out tongue to get a deep enough breath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 02-Jun-2021: Significant follow up appended
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Hypokinesia, Hypopnoea, Ocular discomfort
Clinical narrative: cannot move; cannot open eyes; dizzy; really tired; weak; pain in upper back; sticking out tongue to get a deep enough breath; tingling in feet and hands; itching in feet and hands; swelling in feet and hands; pressure on chest; shallow breathing; wheezing; throat closed up; whole body swelled up; ears ringing; easily agitated; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling in feet and hands), PRURITUS (itching in feet and hands), PERIPHERAL SWELLING (swelling in feet and hands), CHEST DISCOMFORT (pressure on chest) and HYPOPNOEA (shallow breathing) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No Adverse Events. Concomitant products included ZOLPIDEM TARTRATE (AMBIEN) for Product used for unknown indication, ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.    On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, the patient experienced PARAESTHESIA (tingling in feet and hands), PRURITUS (itching in feet and hands), PERIPHERAL SWELLING (swelling in feet and hands), CHEST DISCOMFORT (pressure on chest), HYPOPNOEA (shallow breathing), WHEEZING (wheezing), OROPHARYNGEAL DISCOMFORT (throat closed up), SWELLING (whole body swelled up), TINNITUS (ears ringing) and AGITATION (easily agitated). On 02-Jun-2021, the patient experienced HYPOKINESIA (cannot move), OCULAR DISCOMFORT (cannot open eyes), DIZZINESS (dizzy), FATIGUE (really tired), ASTHENIA (weak), BACK PAIN (pain in upper back) and DYSPNOEA (sticking out tongue to get a deep enough breath). On 20-May-2021, CHEST DISCOMFORT (pressure on chest), HYPOPNOEA (shallow breathing), WHEEZING (wheezing), OROPHARYNGEAL DISCOMFORT (throat closed up), SWELLING (whole body swelled up), TINNITUS (ears ringing) and AGITATION (easily agitated) outcome was unknown. At the time of the report, PARAESTHESIA (tingling in feet and hands), PRURITUS (itching in feet and hands), PERIPHERAL SWELLING (swelling in feet and hands), HYPOKINESIA (cannot move), OCULAR DISCOMFORT (cannot open eyes), FATIGUE (really tired), ASTHENIA (weak), BACK PAIN (pain in upper back) and DYSPNOEA (sticking out tongue to get a deep enough breath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 02-Jun-2021: Significant follow up appended
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal discomfort, Paraesthesia, Peripheral swelling, Pruritus, Swelling
Clinical narrative: cannot move; cannot open eyes; dizzy; really tired; weak; pain in upper back; sticking out tongue to get a deep enough breath; tingling in feet and hands; itching in feet and hands; swelling in feet and hands; pressure on chest; shallow breathing; wheezing; throat closed up; whole body swelled up; ears ringing; easily agitated; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling in feet and hands), PRURITUS (itching in feet and hands), PERIPHERAL SWELLING (swelling in feet and hands), CHEST DISCOMFORT (pressure on chest) and HYPOPNOEA (shallow breathing) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No Adverse Events. Concomitant products included ZOLPIDEM TARTRATE (AMBIEN) for Product used for unknown indication, ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.    On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, the patient experienced PARAESTHESIA (tingling in feet and hands), PRURITUS (itching in feet and hands), PERIPHERAL SWELLING (swelling in feet and hands), CHEST DISCOMFORT (pressure on chest), HYPOPNOEA (shallow breathing), WHEEZING (wheezing), OROPHARYNGEAL DISCOMFORT (throat closed up), SWELLING (whole body swelled up), TINNITUS (ears ringing) and AGITATION (easily agitated). On 02-Jun-2021, the patient experienced HYPOKINESIA (cannot move), OCULAR DISCOMFORT (cannot open eyes), DIZZINESS (dizzy), FATIGUE (really tired), ASTHENIA (weak), BACK PAIN (pain in upper back) and DYSPNOEA (sticking out tongue to get a deep enough breath). On 20-May-2021, CHEST DISCOMFORT (pressure on chest), HYPOPNOEA (shallow breathing), WHEEZING (wheezing), OROPHARYNGEAL DISCOMFORT (throat closed up), SWELLING (whole body swelled up), TINNITUS (ears ringing) and AGITATION (easily agitated) outcome was unknown. At the time of the report, PARAESTHESIA (tingling in feet and hands), PRURITUS (itching in feet and hands), PERIPHERAL SWELLING (swelling in feet and hands), HYPOKINESIA (cannot move), OCULAR DISCOMFORT (cannot open eyes), FATIGUE (really tired), ASTHENIA (weak), BACK PAIN (pain in upper back) and DYSPNOEA (sticking out tongue to get a deep enough breath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 02-Jun-2021: Significant follow up appended
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus, Wheezing
Clinical narrative: cannot move; cannot open eyes; dizzy; really tired; weak; pain in upper back; sticking out tongue to get a deep enough breath; tingling in feet and hands; itching in feet and hands; swelling in feet and hands; pressure on chest; shallow breathing; wheezing; throat closed up; whole body swelled up; ears ringing; easily agitated; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling in feet and hands), PRURITUS (itching in feet and hands), PERIPHERAL SWELLING (swelling in feet and hands), CHEST DISCOMFORT (pressure on chest) and HYPOPNOEA (shallow breathing) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No Adverse Events. Concomitant products included ZOLPIDEM TARTRATE (AMBIEN) for Product used for unknown indication, ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.    On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, the patient experienced PARAESTHESIA (tingling in feet and hands), PRURITUS (itching in feet and hands), PERIPHERAL SWELLING (swelling in feet and hands), CHEST DISCOMFORT (pressure on chest), HYPOPNOEA (shallow breathing), WHEEZING (wheezing), OROPHARYNGEAL DISCOMFORT (throat closed up), SWELLING (whole body swelled up), TINNITUS (ears ringing) and AGITATION (easily agitated). On 02-Jun-2021, the patient experienced HYPOKINESIA (cannot move), OCULAR DISCOMFORT (cannot open eyes), DIZZINESS (dizzy), FATIGUE (really tired), ASTHENIA (weak), BACK PAIN (pain in upper back) and DYSPNOEA (sticking out tongue to get a deep enough breath). On 20-May-2021, CHEST DISCOMFORT (pressure on chest), HYPOPNOEA (shallow breathing), WHEEZING (wheezing), OROPHARYNGEAL DISCOMFORT (throat closed up), SWELLING (whole body swelled up), TINNITUS (ears ringing) and AGITATION (easily agitated) outcome was unknown. At the time of the report, PARAESTHESIA (tingling in feet and hands), PRURITUS (itching in feet and hands), PERIPHERAL SWELLING (swelling in feet and hands), HYPOKINESIA (cannot move), OCULAR DISCOMFORT (cannot open eyes), FATIGUE (really tired), ASTHENIA (weak), BACK PAIN (pain in upper back) and DYSPNOEA (sticking out tongue to get a deep enough breath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 02-Jun-2021: Significant follow up appended
Sex: U
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication history not provided by reporter. Treatment information was unknown.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Hot flush, Myalgia
Clinical narrative: headache; muscle ache; chills; Hot flashes; Fatigue; fever; soreness in the arm; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (soreness in the arm), HEADACHE (headache), MYALGIA (muscle ache), CHILLS (chills) and HOT FLUSH (Hot flashes) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 025C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported by the reporter.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced PAIN IN EXTREMITY (soreness in the arm). On 18-May-2021, the patient experienced HEADACHE (headache), MYALGIA (muscle ache), CHILLS (chills), HOT FLUSH (Hot flashes), FATIGUE (Fatigue) and PYREXIA (fever). At the time of the report, PAIN IN EXTREMITY (soreness in the arm), HEADACHE (headache), MYALGIA (muscle ache), CHILLS (chills), HOT FLUSH (Hot flashes), FATIGUE (Fatigue) and PYREXIA (fever) outcome was unknown.            This case was linked to MOD-2021-162026 (Patient Link).
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: headache; muscle ache; chills; Hot flashes; Fatigue; fever; soreness in the arm; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (soreness in the arm), HEADACHE (headache), MYALGIA (muscle ache), CHILLS (chills) and HOT FLUSH (Hot flashes) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 025C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported by the reporter.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced PAIN IN EXTREMITY (soreness in the arm). On 18-May-2021, the patient experienced HEADACHE (headache), MYALGIA (muscle ache), CHILLS (chills), HOT FLUSH (Hot flashes), FATIGUE (Fatigue) and PYREXIA (fever). At the time of the report, PAIN IN EXTREMITY (soreness in the arm), HEADACHE (headache), MYALGIA (muscle ache), CHILLS (chills), HOT FLUSH (Hot flashes), FATIGUE (Fatigue) and PYREXIA (fever) outcome was unknown.            This case was linked to MOD-2021-162026 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: received 2nd dose of Moderna vaccine on D21st, after receiving the 1st dose of vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received 2nd dose of Moderna vaccine on D21st, after receiving the 1st dose of vaccine) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received 2nd dose of Moderna vaccine on D21st, after receiving the 1st dose of vaccine). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received 2nd dose of Moderna vaccine on D21st, after receiving the 1st dose of vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to US-MODERNATX, INC.-MOD-2021-162303 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-162303:
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Throat irritation
Clinical narrative: Testes for Covid-19 after first shot of Moderna vaccine; Slight cough; Little bit of tickling throat; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Testes for Covid-19 after first shot of Moderna vaccine), COUGH (Slight cough) and THROAT IRRITATION (Little bit of tickling throat) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-May-2021, the patient experienced COVID-19 (Testes for Covid-19 after first shot of Moderna vaccine), COUGH (Slight cough) and THROAT IRRITATION (Little bit of tickling throat). At the time of the report, COVID-19 (Testes for Covid-19 after first shot of Moderna vaccine), COUGH (Slight cough) and THROAT IRRITATION (Little bit of tickling throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: Sore Throat; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore Throat) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (Sore Throat). At the time of the report, OROPHARYNGEAL PAIN (Sore Throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information was provided.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: report side effect; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (report side effect) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced ADVERSE REACTION (report side effect). At the time of the report, ADVERSE REACTION (report side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was provided.  No treatment medication information was provided.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dyspnoea, Fatigue, Headache, Influenza like illness
Clinical narrative: Vaccination site rash; Vaccination site redness; Vaccination site  itching; Flu-like Symptoms; joint pain; fatigue; nausea; injection site pain; headache; Shortness of breath; swelling; warmth; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), SWELLING (swelling), VACCINATION SITE WARMTH (warmth), INFLUENZA LIKE ILLNESS (Flu-like Symptoms) and INJECTION SITE PAIN (injection site pain) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Ceclor , codeine), Multiple myeloma since 19-Oct-2020, Sick sinus syndrome since 01-Jan-2017, Asthma since 02-Jan-1976, Sleep apnoea since 01-Jun-2000 and Hypotension since 31-Oct-2000. Concomitant products included METOPROLOL SUCCINATE (TOPROL XL) from 01-Jan-2016 to an unknown date for Angina pectoris, RIVAROXABAN (XARELTO) from 01-Aug-2019 to an unknown date for Anticoagulant therapy, LEVOSALBUTAMOL HYDROCHLORIDE (XOPENEX) from 01-Oct-2018 to an unknown date for Bronchospasm, IVABRADINE HYDROCHLORIDE (CORLANOR) from 01-May-2018 to an unknown date for Congestive heart failure, GABAPENTIN (NEURONTIN) from 01-Jan-2019 to an unknown date for Neuropathy.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced DYSPNOEA (Shortness of breath), SWELLING (swelling), VACCINATION SITE WARMTH (warmth), INJECTION SITE PAIN (injection site pain) and HEADACHE (headache). On 04-Feb-2021, the patient experienced NAUSEA (nausea). On 05-Feb-2021, the patient experienced FATIGUE (fatigue). On 09-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like Symptoms) and ARTHRALGIA (joint pain). On 12-Feb-2021, the patient experienced VACCINATION SITE RASH (Vaccination site rash), VACCINATION SITE ERYTHEMA (Vaccination site redness) and VACCINATION SITE PRURITUS (Vaccination site  itching). The patient was treated with EPINEPHRINE (EPIPEN) for Shortness of breath, at a dose of 1 dosage form and PARACETAMOL (TYLENOL) (oral) for Headache, at a dose of 1 dosage form. On 11-Feb-2021, INFLUENZA LIKE ILLNESS (Flu-like Symptoms) had resolved. On 17-Feb-2021, VACCINATION SITE RASH (Vaccination site rash) and VACCINATION SITE ERYTHEMA (Vaccination site redness) had resolved, VACCINATION SITE PRURITUS (Vaccination site  itching) outcome was unknown. At the time of the report, DYSPNOEA (Shortness of breath) had resolved and SWELLING (swelling), VACCINATION SITE WARMTH (warmth), INJECTION SITE PAIN (injection site pain), HEADACHE (headache), NAUSEA (nausea), FATIGUE (fatigue) and ARTHRALGIA (joint pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Nausea, Swelling, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Vaccination site rash; Vaccination site redness; Vaccination site  itching; Flu-like Symptoms; joint pain; fatigue; nausea; injection site pain; headache; Shortness of breath; swelling; warmth; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), SWELLING (swelling), VACCINATION SITE WARMTH (warmth), INFLUENZA LIKE ILLNESS (Flu-like Symptoms) and INJECTION SITE PAIN (injection site pain) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Ceclor , codeine), Multiple myeloma since 19-Oct-2020, Sick sinus syndrome since 01-Jan-2017, Asthma since 02-Jan-1976, Sleep apnoea since 01-Jun-2000 and Hypotension since 31-Oct-2000. Concomitant products included METOPROLOL SUCCINATE (TOPROL XL) from 01-Jan-2016 to an unknown date for Angina pectoris, RIVAROXABAN (XARELTO) from 01-Aug-2019 to an unknown date for Anticoagulant therapy, LEVOSALBUTAMOL HYDROCHLORIDE (XOPENEX) from 01-Oct-2018 to an unknown date for Bronchospasm, IVABRADINE HYDROCHLORIDE (CORLANOR) from 01-May-2018 to an unknown date for Congestive heart failure, GABAPENTIN (NEURONTIN) from 01-Jan-2019 to an unknown date for Neuropathy.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced DYSPNOEA (Shortness of breath), SWELLING (swelling), VACCINATION SITE WARMTH (warmth), INJECTION SITE PAIN (injection site pain) and HEADACHE (headache). On 04-Feb-2021, the patient experienced NAUSEA (nausea). On 05-Feb-2021, the patient experienced FATIGUE (fatigue). On 09-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like Symptoms) and ARTHRALGIA (joint pain). On 12-Feb-2021, the patient experienced VACCINATION SITE RASH (Vaccination site rash), VACCINATION SITE ERYTHEMA (Vaccination site redness) and VACCINATION SITE PRURITUS (Vaccination site  itching). The patient was treated with EPINEPHRINE (EPIPEN) for Shortness of breath, at a dose of 1 dosage form and PARACETAMOL (TYLENOL) (oral) for Headache, at a dose of 1 dosage form. On 11-Feb-2021, INFLUENZA LIKE ILLNESS (Flu-like Symptoms) had resolved. On 17-Feb-2021, VACCINATION SITE RASH (Vaccination site rash) and VACCINATION SITE ERYTHEMA (Vaccination site redness) had resolved, VACCINATION SITE PRURITUS (Vaccination site  itching) outcome was unknown. At the time of the report, DYSPNOEA (Shortness of breath) had resolved and SWELLING (swelling), VACCINATION SITE WARMTH (warmth), INJECTION SITE PAIN (injection site pain), HEADACHE (headache), NAUSEA (nausea), FATIGUE (fatigue) and ARTHRALGIA (joint pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.